The Pharmacokinetics of ER OROS Paliperidone in Subjects With Varying Degrees of Impaired Renal Function (Mild, Moderate, and Severe) as Compared to Subjects With Normal Renal Function.
Phase of Trial: Phase I
Latest Information Update: 09 Jun 2011
At a glance
- Drugs Paliperidone (Primary)
- Indications Psychotic disorders
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 10 Jun 2017 Biomarkers information updated
- 28 Nov 2008 New trial record.